The Graft is a tube-shaped synthetic material, which is being used to patch injured or diseased area of arteries or veins. It is applied to redirect the flow of blood and restore normal blood flow within the body. The global vascular graft market is rising at a significant pace due to rapid growth in geriatric population increasing prevalence of diabetes and cardiovascular disease and increasing prevalence of smoking. The market has seen a high demand for endovascular aneurysm over the last few years, due to the growing geriatric population and increasing demand for minimally invasive surgical procedures.

Request for Free Sample Copy of this Research Report at: https://www.vynzresearch.com/healthcare/vascular-graft-market/request-sample

Market Segmentation
Insight by Raw Material

Worldwide vascular graft market has also been subdivided by raw material into polyurethane grafts, polyester grafts, ePTFE grafts, and biosynthetic grafts. Polyester graft holds a significantly larger share in the market due to the high demand for polyester material due to its benefits such as larger lifespan, better absorbency of polyester grafts and high patency.

Insight by Indication

The global vascular graft market has also been classified by indication into hemodialysis access, endovascular aneurysm repair (EVAR), and peripheral vascular repair. The endovascular aneurysm repair is the most common indication contributing the largest revenue to the global market and the demand for vascular graft products is expected to grow at the fastest rate for the same indication during the projected period due to growing geriatric population, escalating acceptance of endovascular aneurysm repair surgical procedures for conditions like as abnormal aortic disorders or aneurysm, and mounting preference for minimally invasive surgical procedures.

Insight by End-User

The different type of end users are hospitals and ambulatory surgical centers. The hospitals are the biggest end-user category and is expected to exhibit grow the faster growth in demand for the vascular graft products due to promising reimbursement scenario for graft procedures in the developed countries, the increasing prevalence of cardiovascular diseases, increasing prevalence of end-stage renal disease and increasing adoption of a minimally invasive procedure in hospitals.

Industry Dynamics

Industry Trends

Due to development of biosynthetic vascular graft is the major trend in the vascular graft market. The demand for biosynthetic graft is rising due to biocompatibility, exceptional re-infection resistance and rising acceptance among patients.

Growth Drivers

The speedy increase in aging population, increasing the prevalence of cardiovascular diseases, the growing prevalence of vascular disorders, increasing prevalence of diabetes and escalating acceptance of minimally invasive surgeries are the primary growth drivers for the global market. According to the World Health Organization (WHO), in 2015 approximately 17.7 million people died due to cardiovascular disease worldwide. The rising prevalence of smoking and increasing prevalence of end-stage renal disease (ESRD) are also fueling the growth of the vascular graft industry. According to the WHO, approximately 1.1 billion smokers live in low and middle-income countries.

Challenges

Due to the product failure and recall, the high cost of treatment, and risk of infection and complications are the major challenge for the growth of the vascular graft market. Some of the complications associated with grafts are sepsis, disruption of infected anastomotic rigid line, and amputation.

Industry Ecosystem

The main challenge for the new entrants is the survival in capital intensive and highly regulated vascular graft market. In addition, there is less product differentiation offered by current players, which further increases the competition among the existing players.

Browse Full Research Report Description at: https://www.vynzresearch.com/healthcare/vascular-graft-market

Geographic Overview

Globally, North America is the biggest vascular graft market due to rising healthcare expenditure, increasing the prevalence of diabetes, increasing government initiatives and increasing research and development.

Few of the other factors leading to the growth of the North American vascular graft market are increasing geriatric population, increasing the prevalence of ESRD, increasing the prevalence of cardiovascular disease and increasing adoption of minimally invasive surgeries. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Moreover, according to CDC in 2017 approximately, 30 million people in the U.S. have chronic kidney disease, and in 2014 approximately 118,000 people in the U.S. started treatment for ESRD.

Asia-Pacific especially India, China, Korea, Japan is observed to witness the fastest growth in the market as the region comprises of largest population and healthcare infrastructure is improving. Apart from this, growing geriatric population, the increasing number of smokers, increasing medical tourism, and growing adoption of minimally invasive procedures are creating a positive impact on the vascular graft market growth in the region.

Competitive Insight

Major players in the vascular graft industry are investing in the development of innovative and advance graft products, which is strengthening their position in the market. In January 2017, Terumo Corporation completed an acquisition of vascular closure business and other assets of Abbott and St. Jude Medical. In addition, in May 2017, Medtronic announced the enrollment of the first patient with the end-stage renal disease in the IN. PACT AV Access Drug-Coated Balloon (DCB) study.

Medtronic Plc, Terumo Corporation, Maquet, C. R. Bard, B. Braun Melsungen AG, Lemaitre Vascular, Cardinal Health, Endologix, Cook Medical Inc., and W.L. Gore & Associates Inc., are some of the key players offering vascular graft products.

About VynZ Research

VynZ Research is the leading research and advisory company. We’ve grown well beyond our leading technology research to provide management across the enterprise with the vital information, advice and tools they need to achieve their goal/mission-critical priorities and build the organizations of future.

Together with our customers, we fuel the future of business so that a more successful world takes shape.

Contact

Kundan Kumar
Manager: Client Care

VynZ Research
Direct: +919960288381
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: [email protected]